Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes

[1]  Y. Ouyang,et al.  Blood-brain barrier and neuro-AIDS. , 2015, European review for medical and pharmacological sciences.

[2]  S. Tenn,et al.  Transferrin receptors and glioblastoma multiforme: Current findings and potential for treatment , 2015, Journal of Clinical Neuroscience.

[3]  A. Brik,et al.  The U4/U6 Recycling Factor SART3 Has Histone Chaperone Activity and Associates with USP15 to Regulate H2B Deubiquitination* , 2014, The Journal of Biological Chemistry.

[4]  T. Terasaki,et al.  Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model. , 2013, Molecular pharmaceutics.

[5]  P. Couraud,et al.  The hCMEC/D3 cell line as a model of the human blood brain barrier , 2013, Fluids and Barriers of the CNS.

[6]  Jessica M. Winkler,et al.  The National NeuroAIDS Tissue Consortium Brain Gene Array: Two Types of HIV-Associated Neurocognitive Impairment , 2012, PloS one.

[7]  Leaf Huang,et al.  Recent advances in nonviral vectors for gene delivery. , 2012, Accounts of chemical research.

[8]  Lihong Liu,et al.  Modern methods for delivery of drugs across the blood-brain barrier. , 2012, Advanced drug delivery reviews.

[9]  Giuseppe Trapani,et al.  Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery. , 2011, International journal of pharmaceutics.

[10]  N. Selvamurugan,et al.  Chitosan and its derivatives for gene delivery. , 2011, International journal of biological macromolecules.

[11]  Silvia Deaglio,et al.  Transferrin receptor 2 is frequently and highly expressed in glioblastomas. , 2010, Translational oncology.

[12]  X. Wu,et al.  Nanotechnology applications for improved delivery of antiretroviral drugs to the brain. , 2010, Advanced drug delivery reviews.

[13]  N. K. Jain,et al.  Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting. , 2010, Advanced drug delivery reviews.

[14]  Robert Langer,et al.  Knocking down barriers: advances in siRNA delivery , 2009, Nature Reviews Drug Discovery.

[15]  Meredith A Mintzer,et al.  Nonviral vectors for gene delivery. , 2009, Chemical reviews.

[16]  Saroj P. Mathupala,et al.  Delivery of small-interfering RNA (siRNA) to the brain , 2009, Expert opinion on therapeutic patents.

[17]  Yunhui Liu,et al.  Low dose of bradykinin selectively increases intracellular calcium in glioma cells , 2007, Journal of the Neurological Sciences.

[18]  E. Shusta,et al.  Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation , 2007, Pharmaceutical Research.

[19]  W. Pardridge.  shRNA and siRNA delivery to the brain. , 2007, Advanced drug delivery reviews.

[20]  Patrick Couvreur,et al.  Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26. , 2005, Bioconjugate chemistry.

[21]  P. An,et al.  Study of correlation between expression of bradykinin B2 receptor and pathological grade in human gliomas , 2005, British journal of neurosurgery.

[22]  T. Rana,et al.  Inhibition of Human Immunodeficiency Virus Type 1 Replication by RNA Interference Directed against Human Transcription Elongation Factor P-TEFb (CDK9/CyclinT1) , 2004, Journal of Virology.

[23]  Hongzhe Sun,et al.  Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway , 2002, Pharmacological Reviews.

[24]  P. Fisher,et al.  Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH , 2002, Oncogene.

[25]  D D Allen,et al.  Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier , 2002, Drug development and industrial pharmacy.

[26]  H. Adle-Biassette,et al.  Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. , 2001, Clinical neuropathology.

[27]  D. Janigro,et al.  The blood-brain barrier and AIDS. , 2001, Advances in virus research.

[28]  B. Engelhardt,et al.  Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. , 2000, The Journal of pharmacology and experimental therapeutics.

[29]  K. Bhoola,et al.  Kinin receptors are expressed in human astrocytic tumour cells. , 1999, Immunopharmacology.

[30]  G. Simmons,et al.  Primary Human Immunodeficiency Virus Type 2 (HIV-2) Isolates Infect CD4-Negative Cells via CCR5 and CXCR4: Comparison with HIV-1 and Simian Immunodeficiency Virus and Relevance to Cell Tropism In Vivo , 1999, Journal of Virology.

[31]  R. Klein,et al.  Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS. , 1999, Journal of immunology.

[32]  R. Abrams,et al.  HIV-associated primary CNS lymorbidity and utility of brain biopsy , 1999, Journal of the Neurological Sciences.

[33]  B. Engelhardt,et al.  Immunohistochemical localization of the murine transferrin receptor (TfR) on blood–tissue barriers using a novel anti-TfR monoclonal antibody , 1998, Histochemistry and Cell Biology.

[34]  P. Lantos,et al.  HIV‐associated brain pathology: a comparative international study , 1998, Neuropathology and applied neurobiology.

[35]  J. Howard,et al.  Restricted HIV-1 infection of human astrocytes: potential role of nef in the regulation of virus replication. , 1998, Journal of neurovirology.

[36]  J. Berman,et al.  The role of the blood-brain barrier in HIV infection of the central nervous system. , 1994, Advances in neuroimmunology.

[37]  G. Wilkin,et al.  Calcium‐mobilizing and electrophysiological effects of bradykinin on cortical astrocyte subtypes in culture , 1993, Glia.

[38]  B Marc,et al.  Early Brain Changes in HIV Infection: Neuropathological Study of 11 HIV Seropositive, Non‐AIDS Cases , 1992, Journal of neuropathology and experimental neurology.

[39]  A. Cholewinski,et al.  Identification of B2 Bradykinin Binding Sites on Cultured Cortical Astrocytes , 1991, Journal of neurochemistry.

[40]  P. Lin,et al.  Brain-derived cells contain a specific binding site for Gp20 which is not the CD4 antigen , 1991, Brain Research.

[41]  J. Weber,et al.  Infection of brain cells by diverse human immunodeficiency virus isolates: role of CD4 as receptor. , 1989, The Journal of general virology.

[42]  W. Jefferies,et al.  Transferrin receptor on endothelium of brain capillaries , 1984, Nature.